Endogenex

Endogenex is a privately held clinical-stage company. Endogenex was co-founded with the Mayo Clinic to develop therapies that improve outcomes for patients with type 2 diabetes. Endogenex focuses on the effective treatment of type 2 diabetes, which can go beyond drug options, correct metabolic function, and help people regain control of their blood sugar levels.